What were the most popular articles of the Kluwer Patent Blog in 2021? Some topics keep on returning, but new issues found their way into the chart of best read posts on this blog as well.
The number…
At the beginning of the year, the Russian Government granted the first compulsory license on a series of Big Pharma's patents.
For the first time ever, "public security” clause has been evoked…
In a judgment in preliminary proceedings the Bundespatentgericht (German Federal Patent Court) granted the pharmaceutical company Merck the right to use European patent EP 1 422 218 and to continue…
